Assessment of the Mode of Action Underlying the Effects of GenX in Mouse Liver and Implications for Assessing Human Health Risks
11 Mar 2020 | Toxicol Pathol
GenX found to change liver function through interruption of receptors such as PPARα.
Removing per‐ and polyfluoroalkyl substances from groundwaters using activated carbon and ion exchange resin packed columns
10 Mar 2020 | Water Science
Different types of PFAS filtering techniques were compared with advantages and disadvantages depending on filter type, media, and target PFAS.
Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl Substances
10 Mar 2020 | Int J Environ Res Public Health
Evidence shows that several PFAS exhibit one or more key characteristics that cause cancer.
Managing health risks of perfluoroalkyl acids in aquatic food from a river-estuary-sea environment affected by fluorochemical industry
10 Mar 2020 | Environ Int
This study provides recommendations for mitigating the health risks of PFAS-contaminated aquatic food, ranging from food selection to consumption frequency and proper food processing.
A framework to model exposure to per- and polyfluoroalkyl substances in indoor environments
10 Mar 2020 | Environ Sci Process Impacts
A brief review of what has been done to assess indoor exposure to PFAS is followed by a proposed systematic indoor exposure framework for PFAS based on methods to estimate exposure of these semivolatile organic compounds.
The phase out of and restrictions on per-and polyfluoroalkyl substances: Time for a rethink
9 Mar 2020 | Chemosphere
Leading scientists call for more increased communication, collaboration, and transparency between academia and industry so countries can contribute meaningfully to global regulatory initiatives.
Exposures to per-and polyfluoroalkyl substances (PFAS): Potential risks to reproductive and children's health
9 Mar 2020 | Curr Probl Pediatr Adolesc Health Care
A review of PFAS's effect on developing children and potential routes of exposure.
Phototransformation of perfluorooctane sulfonamide on natural clay minerals: A likely source of short chain perfluorocarboxylic acids
3 Mar 2020 | J. of Haz. Mat.
This study provides the first evidence that FOSA may break down in the presence of natural clay minerals and act as an important source of PFAS, especially short-chain PFAS.
Exposure to Perfluoroalkyl Substances in a Cohort of Women Firefighters and Office Workers in San Francisco
3 Mar 2020 | Environ. Sci. Technol.
Women firefighters are exposed to higher levels of some PFAS compared to office workers, suggesting that some of these exposures may be occupationally related.
Albumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma
3 Mar 2020 | Environ Int
Albumin was found to be the most important carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human blood.
Environmental contamination and human exposure to PFASs near a fluorochemical production plant: Review of historic and current PFOA and GenX contamination in the Netherlands
3 Mar 2020 | Environ Int
This paper provides a comprehensive overview of PFOA and GenX contamination close to point sources in the Netherlands.
Perfluoroalkyl Substances Stimulate Insulin Secretion by Islet β Cells via G Protein-Coupled Receptor 40
3 Mar 2020 | Environ. Sci. Technol.
Evidence for a novel mechanism for how PFASs disrupt insulin-secretion in a human was discovered.
Visualized Metabolic Disorder and its Chemical Inducer in Wild Crucian Carp from Taihu Lake, China
3 Mar 2020 | Environ. Sci. Technol.
Perfluoroundecanoic acid (PFUnDA) was the key pollutant responsible for variation in blood triglycerides and fatty livers in wild crucian carp.
Impacts of food contact chemicals on human health: a consensus statement
2 Mar 2020 | Environmental Health
33 scientists wrote a peer-reviewed consensus statement highlighting toxic chemicals in food packaging and recommended improvements to protect human health.
Per- and Polyfluoroalkyl Substances: An Emerging Contaminant of Concern
2 Mar 2020 | Ann. Rev. of Nur. Res.
This chapter discusses the health harm associated with PFAS, exposure and risk reduction, advisory levels, and medical testing/management.